LJAC
GILD icon

L.J. Altfest & Co’s Gilead Sciences GILD Stock Holding History

L.J. Altfest & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$225K Sell
1,783
-65
-4% -$8.56K 0.02% 295
2026
Q1 		$257K Sell
1,848
-67
-3% -$9.38K 0.03% 287
2025
Q4 		$235K Sell
1,915
-4,944
-72% -$601K 0.03% 309
2025
Q3 		$761K Buy
6,859
+2,342
+52% +$266K 0.08% 164
2025
Q2 		$501K Buy
+4,517
New +$481K 0.06% 215
2024
Q1 		– Sell
-2,598
Closed -$210K – 321
2023
Q4 		$210K Buy
+2,598
New +$202K 0.03% 289
2023
Q3 		– Sell
-2,844
Closed -$219K – 297
2023
Q2 		$219K Sell
2,844
-903
-24% -$72K 0.03% 276
2023
Q1 		$311K Sell
3,747
-301
-7% -$24.9K 0.05% 216
2022
Q4 		$348K Sell
4,048
-263
-6% -$20.8K 0.06% 196
2022
Q3 		$266K Buy
4,311
+4
+0.1% +$252 0.05% 224
2022
Q2 		$266K Sell
4,307
-70
-2% -$4.33K 0.05% 218
2022
Q1 		$260K Sell
4,377
-31
-0.7% -$1.98K 0.05% 221
2021
Q4 		$320K Sell
4,408
-10
-0.2% -$689 0.06% 202
2021
Q3 		$309K Sell
4,418
-4,269
-49% -$300K 0.06% 204
2021
Q2 		$598K Sell
8,687
-5
-0.1% -$334 0.13% 122
2021
Q1 		$562K Buy
8,692
+4,214
+94% +$272K 0.13% 123
2020
Q4 		$261K Buy
+4,478
New +$270K 0.06% 218
2020
Q3 		– Sell
-2,714
Closed -$209K – 236
2020
Q2 		$209K Sell
2,714
-68
-2% -$5.21K 0.06% 202
2020
Q1 		$208K Sell
2,782
-2,587
-48% -$179K 0.07% 180
2019
Q4 		$349K Buy
+5,369
New +$350K 0.09% 139
2019
Q2 		– Sell
-3,206
Closed -$208K – 191
2019
Q1 		$208K Buy
+3,206
New +$213K 0.05% 177
2018
Q4 		– Sell
-3,756
Closed -$290K – 165
2018
Q3 		$290K Sell
3,756
-152
-4% -$11.5K 0.08% 138
2018
Q2 		$277K Sell
3,908
-8,015
-67% -$566K 0.1% 137
2018
Q1 		$899K Buy
+11,923
New +$948K 0.39% 60

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

L.J. Altfest & Co's GILD Position: Q2 2026 in Review

L.J. Altfest & Co reduced its Gilead Sciences (GILD) stake by 3.5% in Q2 2026, selling an estimated $8.56K and leaving 1,783 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #295.

L.J. Altfest & Co first reported a position in GILD in Q1 2018 and has held it in 24 quarters since. The position peaked at $899K in Q1 2018. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • L.J. Altfest & Co held 1,783 shares of Gilead Sciences worth $225K as of Q2 2026.
  • L.J. Altfest & Co sold 65 Gilead Sciences shares in Q2 2026, an estimated $8.56K.
  • Gilead Sciences made up 0.02% of L.J. Altfest & Co's portfolio in Q2 2026, its #295 holding.
  • L.J. Altfest & Co first reported a position in Gilead Sciences in Q1 2018 and has held it in 24 quarters since.
  • L.J. Altfest & Co's Gilead Sciences position peaked at $899K in Q1 2018.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on L.J. Altfest & Co's 13F filing for Q2 2026, filed 30 Jul 2026.